Medukator.hu

A tartós kortikoszteroid kezelés mellékhatásai

Utolsó módosítás: 2013-06-03 18:06|
Szerző: dr. Kalabay László.

Kortikoszteroidokat számos indikációval adunk, leggyakrabban gyulladásos és daganatos betegségekben. Alkalmazásuk számos potenciálisan súlyos mellékhatás kialakulásával jár. Ezek jelentős részét gondos ellenőrzéssel és preventív intézkedésekkel minimalizálni lehet. A mellékhatások megjelenése elsősorban a kezelés tartósságától, másodsorban az alkalmazott dózistól függ..

A teljes tartalom megtekintéséhez, kérem, jelentkezzen be, vagy regisztráljon oldalunkon!

hirdetés

Allergia

Tudáspróba

Sclerosis multiplex (SM)

Méhen kívüli terhesség

Laboratóriumi vizsgálatok

További tudáspróbák...

Friss e-Dokumentumok

EMA Panel Backs Netarsudil for Elevated Intraocular Pressure

Medscape | 2019-09-21 00:01:37

An EMA advisory panel recommended marketing authorization for netarsudil ophthalmic solution 0.02% for the treatment of adults with glaucoma or ocular hypertension. International Approvals

EMA Panel Backs Anesthetic Spray for Premature Ejaculation

Medscape | 2019-09-20 23:29:10

Senstend, a spray containing lidocaine/prilocaine, can improve ejaculatory control and sexual satisfaction and reduce distress related to ejaculation, the EMA said. International Approvals

EMA Panel Backs Belimumab for Children With Lupus

Medscape | 2019-09-20 23:08:15

An EMA panel recommended extending the indication for belimumab to children aged 5 years and older with systemic lupus erythematosus. International Approvals

EU Panel Votes to Expand Dulaglutide Indication Based on REWIND

Medscape | 2019-09-20 22:58:46

The panel also recommends approval of Qtrilmet, a fixed-dose combination of metformin hydrochloride/saxagliptin/dapagliflozin for treatment of type 2 diabetes. International Approvals

MS Risk Nearly Doubles 15 Years Following Teen Concussion

Medscape | 2019-09-20 22:24:35

An association between concussion during adolescence and long-term, elevated risk for multiple sclerosis grew stronger with new evidence from a large study. Medscape Medical News

Adding Patiromer Allows More Spironolactone in Resistant HTN, CKD

Medscape | 2019-09-20 21:36:10

With or without heart failure, add-on treatment with the potassium sequestrant 'enabled' more intensive use of the aldosterone blocker otherwise limited by hyperkalemia, according to the AMBER...

FDA OKs Packaging for OTC Loperamide to Help Stem Misuse, Abuse

Medscape | 2019-09-20 21:15:30

The changes to Imodium A-D, Imodium Multi-Symptom Relief, and Be Health Loperamide HCl Capsules limit each carton to no more than 48 mg of loperamide and require unit-dose blister packaging. News...

FDA Expands Indications for Pifeltro and Delstrigo for HIV

Medscape | 2019-09-20 20:43:42

The FDA expanded the indications for the two HIV drugs to include appropriate patients with HIV-1 with virological suppression. FDA Approvals

New Drug Pricing Bill Allows Negotiation With Pharma

Medscape | 2019-09-20 19:54:29

Lawmakers are exploring ways to cut drug prices. Major changes in law may be unlikely near-term, but Congress might be able to take a step soon, like capping seniors' Medicare Part D contributions....

Trump Executive Order Aims to Speed Flu Vaccine Development

Medscape | 2019-09-20 19:45:42

The order creates a new task force charged with coming up with a 5-year plan. Medscape Medical News

FDA OKs 'Game-Changer' Oral GLP-1 Agonist for Type 2 Diabetes

Medscape | 2019-09-20 19:24:41

Semaglutide is the first oral glucagon-like peptide-1 receptor agonist. Previously, drugs of this class were available only as injectables. The approval is expected to increase uptake. FDA Approvals

New Option Soon for Some European Patients With Leukemia

Medscape | 2019-09-20 18:02:46

Gilteritinib has been recommended for approval for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) with an FLT3 mutation. International Approvals

Brutal Toll of Osteoporotic Fractures Revealed in New NOF Report

Medscape | 2019-09-20 17:18:00

Osteoporotic fractures are responsible for more hospitalizations than heart attacks, strokes, and breast cancer. "The biggest surprise...is that things are worse than we thought," says...

IUD Use Linked to Reduced Risk of Ovarian Cancer

Medscape | 2019-09-20 16:56:05

Women who use an intrauterine device for contraception have a reduced risk of getting ovarian cancer, according to a new meta-analysis of existing retrospective data. Medscape Medical News

CAROLINA Published: Reaffirms Sulfonylurea Cardiovascular Safety

Medscape | 2019-09-20 16:07:34

The study, presented to a European audience of diabetologists at EASD and simultaneously published in JAMA, reaffirms the CV safety of glimepiride, with calls for FDA warning to be removed....